Washington Trust Advisors, Inc. Laboratory Corp Of America Holdings Transaction History

Washington Trust Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$213.32 - $257.83 $2,986 - $3,609	-14 Reduced 42.42%	19 $4,000
Q4 2022 Feb 08, 2023	SELL	$203.72 - $248.97 $29,131 - $35,602	-143 Reduced 81.25%	33 $7,000
Q3 2022 Oct 14, 2022	BUY	$204.81 - $262.19 $13,927 - $17,828	68 Added 62.96%	176 $36,000
Q2 2022 Jul 25, 2022	BUY	$213.86 - $277.87 $855 - $1,111	4 Added 3.85%	108 $25,000
Q1 2022 May 05, 2022	BUY	$259.82 - $298.18 $21,045 - $24,152	81 Added 352.17%	104 $27,000
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $6,246 - $7,226	23 New	23 $7,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.